Revelation Biosciences, Inc. (REVB)
1.01
0.00 (0.00%)
USD |
NASDAQ |
Sep 09, 12:06
Revelation Biosciences Total Assets (Quarterly) : 12.50M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.50M |
| March 31, 2026 | 15.04M |
| December 31, 2025 | 11.58M |
| September 30, 2025 | 12.86M |
| June 30, 2025 | 5.395M |
| March 31, 2025 | 3.970M |
| December 31, 2024 | 6.622M |
| September 30, 2024 | 6.740M |
| June 30, 2024 | 12.27M |
| March 31, 2024 | 14.70M |
| December 31, 2023 | 12.21M |
| September 30, 2023 | 14.22M |
| June 30, 2023 | 16.04M |
| March 31, 2023 | 18.12M |
| Date | Value |
|---|---|
| December 31, 2022 | 5.503M |
| September 30, 2022 | 6.602M |
| June 30, 2022 | 4.154M |
| March 31, 2022 | 7.98M |
| December 31, 2021 | 2.042M |
| September 30, 2021 | 73.56M |
| June 30, 2021 | 73.89M |
| March 31, 2021 | 74.03M |
| December 31, 2020 | 74.16M |
| September 30, 2020 | 3.499M |
| June 30, 2020 | 0.093M |
| March 31, 2020 | |
| December 31, 2019 | 0.0227M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Shuttle Pharmaceuticals Holdings, Inc. | 11.81M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Agenus, Inc. | 172.69M |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Amgen, Inc. | 95.64B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.431M |
| Shareholders Equity (Quarterly) | 10.07M |
| Debt to Equity Ratio | 0.0735 |
| Current Ratio | 6.214 |
| Net Debt Paydown Yield | -3.68% |